Psychopharmacology of nonepisodic irritability, aggression, and mood swings in children and adolescents part I: Stimulants and antidepressants

Leslie Hulvershorn, David D. Fosselman, Daniel P. Dickstein

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Non-autistic children and adolescents with chronic irritability have presented a diagnostic challenge, dating from the onset of the field of child mental health. Researchers present theories about how to best categorize these children that include existing psychiatric disorders (eg, BD, ADHD, ODD) and novel conceptualizations (eg, SMD). Because diagnostic consensus is difficult to reach, treatment studies specifically targeting irritability and related symptoms are rarely conducted. Thus, information about appropriate pharmacology for these symptoms is derived largely from secondary outcomes of studies conducted on children and adolescents with aggression and disruptive behavior disorders. In this article, we address treatment with stimulants and SSRIs and conclude as follows: Chronic irritability and related symptoms may be successfully treated with stimulants, but only in children and adolescents with ADHD. SSRIs may represent an underutilized option for chronic irritability in nondepressed/subthreshold depressed pediatric patients, but further study is warranted before a clear recommendation can be issued.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalPsychopharm Review
Volume47
Issue number1
DOIs
StatePublished - Jan 2012
Externally publishedYes

Fingerprint

Psychopharmacology
Aggression
Antidepressive Agents
Attention Deficit and Disruptive Behavior Disorders
Psychiatry
Consensus
Mental Health
Research Personnel
Outcome Assessment (Health Care)
Pharmacology
Pediatrics
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Psychopharmacology of nonepisodic irritability, aggression, and mood swings in children and adolescents part I : Stimulants and antidepressants. / Hulvershorn, Leslie; Fosselman, David D.; Dickstein, Daniel P.

In: Psychopharm Review, Vol. 47, No. 1, 01.2012, p. 1-6.

Research output: Contribution to journalArticle

@article{146abdc90c524892bac6c8409ea15211,
title = "Psychopharmacology of nonepisodic irritability, aggression, and mood swings in children and adolescents part I: Stimulants and antidepressants",
abstract = "Non-autistic children and adolescents with chronic irritability have presented a diagnostic challenge, dating from the onset of the field of child mental health. Researchers present theories about how to best categorize these children that include existing psychiatric disorders (eg, BD, ADHD, ODD) and novel conceptualizations (eg, SMD). Because diagnostic consensus is difficult to reach, treatment studies specifically targeting irritability and related symptoms are rarely conducted. Thus, information about appropriate pharmacology for these symptoms is derived largely from secondary outcomes of studies conducted on children and adolescents with aggression and disruptive behavior disorders. In this article, we address treatment with stimulants and SSRIs and conclude as follows: Chronic irritability and related symptoms may be successfully treated with stimulants, but only in children and adolescents with ADHD. SSRIs may represent an underutilized option for chronic irritability in nondepressed/subthreshold depressed pediatric patients, but further study is warranted before a clear recommendation can be issued.",
author = "Leslie Hulvershorn and Fosselman, {David D.} and Dickstein, {Daniel P.}",
year = "2012",
month = "1",
doi = "10.1097/01.PSYPHR.0000410252.86760.05",
language = "English (US)",
volume = "47",
pages = "1--6",
journal = "Psychopharm Review",
issn = "1936-9255",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Psychopharmacology of nonepisodic irritability, aggression, and mood swings in children and adolescents part I

T2 - Stimulants and antidepressants

AU - Hulvershorn, Leslie

AU - Fosselman, David D.

AU - Dickstein, Daniel P.

PY - 2012/1

Y1 - 2012/1

N2 - Non-autistic children and adolescents with chronic irritability have presented a diagnostic challenge, dating from the onset of the field of child mental health. Researchers present theories about how to best categorize these children that include existing psychiatric disorders (eg, BD, ADHD, ODD) and novel conceptualizations (eg, SMD). Because diagnostic consensus is difficult to reach, treatment studies specifically targeting irritability and related symptoms are rarely conducted. Thus, information about appropriate pharmacology for these symptoms is derived largely from secondary outcomes of studies conducted on children and adolescents with aggression and disruptive behavior disorders. In this article, we address treatment with stimulants and SSRIs and conclude as follows: Chronic irritability and related symptoms may be successfully treated with stimulants, but only in children and adolescents with ADHD. SSRIs may represent an underutilized option for chronic irritability in nondepressed/subthreshold depressed pediatric patients, but further study is warranted before a clear recommendation can be issued.

AB - Non-autistic children and adolescents with chronic irritability have presented a diagnostic challenge, dating from the onset of the field of child mental health. Researchers present theories about how to best categorize these children that include existing psychiatric disorders (eg, BD, ADHD, ODD) and novel conceptualizations (eg, SMD). Because diagnostic consensus is difficult to reach, treatment studies specifically targeting irritability and related symptoms are rarely conducted. Thus, information about appropriate pharmacology for these symptoms is derived largely from secondary outcomes of studies conducted on children and adolescents with aggression and disruptive behavior disorders. In this article, we address treatment with stimulants and SSRIs and conclude as follows: Chronic irritability and related symptoms may be successfully treated with stimulants, but only in children and adolescents with ADHD. SSRIs may represent an underutilized option for chronic irritability in nondepressed/subthreshold depressed pediatric patients, but further study is warranted before a clear recommendation can be issued.

UR - http://www.scopus.com/inward/record.url?scp=84855508565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855508565&partnerID=8YFLogxK

U2 - 10.1097/01.PSYPHR.0000410252.86760.05

DO - 10.1097/01.PSYPHR.0000410252.86760.05

M3 - Article

AN - SCOPUS:84855508565

VL - 47

SP - 1

EP - 6

JO - Psychopharm Review

JF - Psychopharm Review

SN - 1936-9255

IS - 1

ER -